Dose Adjustment Considerations in Psychopharmacology
Über den Vortrag
Der Vortrag „Dose Adjustment Considerations in Psychopharmacology“ von Melissa Kalensky, FNP-BC, PMHNP-BC, CNE ist Bestandteil des Kurses „Psychopharmacology Foundations: From Pharmacokinetics to Clinical Practice“.
Quiz zum Vortrag
What is the primary clinical consideration when the half-life of a psychotropic medication is significantly extended in elderly patients?
- Dosing intervals may need to be lengthened to prevent drug accumulation.
- Dosing intervals should be shortened to maintain therapeutic levels.
- The medication should be discontinued immediately due to safety concerns.
- Higher doses are required to achieve the same therapeutic effect.
- Genetic testing becomes mandatory before continuing treatment.
Which advantage makes extended-release formulations particularly beneficial for patients with psychiatric conditions?
- Improved medication adherence through reduced dosing frequency.
- Higher bioavailability compared to immediate-release formulations.
- Faster onset of therapeutic action for acute symptoms.
- Lower cost compared to other medication formulations.
- Elimination of potential side effects seen with other formulations.
Which factor most significantly impacts medication adherence in psychiatric patients according to clinical research?
- Side effects that interfere with daily functioning and quality of life.
- Cost of medications covered by insurance plans.
- Complexity of the pharmacy pickup process.
- Distance from patient's home to the prescribing clinic.
- Availability of generic versions of prescribed medications.
In which clinical scenario would genetic testing be most appropriately implemented for psychotropic medication management?
- When a patient has experienced multiple failed trials with standard dosing.
- Before prescribing any psychotropic medication to any new patient.
- Only when patients specifically request genetic testing services.
- When patients have a family history of any psychiatric condition.
- After patients have been stable on medications for over one year.
Diese Kurse könnten Sie interessieren
Dozent des Vortrages Dose Adjustment Considerations in Psychopharmacology
Melissa Kalensky, FNP-BC, PMHNP-BC, CNE
Dr. Melissa Kalensky, FNP-BC, PMHNP-BC, CNE is dual-certified as a Family Nurse Practitioner and a Psychiatric Mental Health Nurse Practitioner.
She specializes in primary care, community health, and integrated behavioral healthcare. Her expertise spans trauma-informed care and psychiatry across all age groups, from children to adults.
At Lecturio, she teaches psychopharmacology to advanced practice providers, helping to bridge the gap between psychiatric and primary care practice.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
